Announcement • Jun 25

Hend El Sherbini, the Chief Executive Officer of Integrated Diagnostics Holdings plc and Moamena Abdul Wahab Kamel proposed to acquire 50.38% stake in Integrated Diagnostics Holdings plc (LSE:IDHC) for approximately $150 million.

Hend El Sherbini, the Chief Executive Officer of Integrated Diagnostics Holdings plc and Moamena Abdul Wahab Kamel proposed to acquire 50.38% stake in Integrated Diagnostics Holdings plc (LSE:IDHC) for approximately $150 million on June 23, 2026. A cash consideration of $146.44 million valued at $0.5 per share will be paid by the buyer. As part of consideration, $146.44 million is paid towards common equity of Integrated Diagnostics Holdings plc. The Offer values the entire issued and to be issued ordinary share capital of IDH at approximately $290.7 million and represents a discount of approximately 11.2% per cent. to the Closing Price per IDH Share of $0.563 on June 22, 2026. The offer price of $0.50 per IDH Share is final and neither it nor any other person acting in concert with it will increase, or acquire or make an offer for IDH Shares at a price in excess of the offer price. Following completion of the Offer, the existing contractual and employment rights of IDH's management and employees will be respected in accordance with applicable law. It is anticipated that the application for cancellation of admission to trading on the London Stock Exchange and listing on the Official List in such circumstances will take effect no earlier than the date that is 20 Business Days after Bidco has acquired or agreed to acquire sufficient IDH Shares such that it would hold 75% of the voting rights attaching to the IDH Shares. The cancellation of the listing would significantly reduce the liquidity and marketability of the IDH Shares not assented to the Offer at the time. The Offerors will exercise its rights to acquire compulsorily the remaining IDH Shares in respect of which the Offer has not been accepted. The transaction will be financed through equity investment of $107 million and further drawdowns of the remaining RMBV Loan of up to $40 million. In a related transaction, Moamena Abdul Wahab Kamel and Hend El Sherbini of Integrated Diagnostics Holdings plc acquired an additional 21.67% stake in Integrated Diagnostics Holdings plc from Actis LLP for $63 million. In conjunction with the Mandatory Offer, the Board also notes that Richard Henry Phillips has stepped down from the Board with immediate effect. The Offer will be subject to the applicable requirements of the Code, the Panel, the London Stock Exchange and the Financial Conduct Authority, effected by means of a takeover offer within the meaning of Article 116 (1) of the Jersey Companies Law, and Offer becomes unconditional and receives valid acceptances, that together with IDH Shares, would lead to its holding 75% or more of the issued share capital of IDH. Accordingly, IDH shareholders are advised to take no action in respect of the Mandatory Offer at this time. Stuart Andrews and Harry Rees of Canaccord Genuity Limited acted as financial adviser and Baker & McKenzie LLP is retained as legal advise for Moamena Abdul Wahab Kamel and Hend El Sherbini. James Dance, Matthew Chandler, Carl Holmes and Harry Hiley of Strand Hanson Limited acted as financial adviser Integrated Diagnostics Holdings plc.

Integrated Diagnostics Holdings plc Stock Price

IDHC Share Price Performance

IDHC Community Narratives

Acquisition And Branch Expansion Will Unlock Middle East Opportunities

Egypt, Nigeria Risks Will Curtail Prospects Yet Saudi Will Emerge

Digital And House-Call Diagnostics Will Transform MENA Healthcare Delivery

Acquisition And Branch Expansion Will Unlock Middle East Opportunities

Egypt, Nigeria Risks Will Curtail Prospects Yet Saudi Will Emerge

Digital And House-Call Diagnostics Will Transform MENA Healthcare Delivery

Trending Discussion

Recently Updated Narratives

IDHC: Maintained Fair Value And Confirmed 2025 Dividend Will Support Upside

IDHC: Dividend Visibility And Higher Revenue Assumptions Will Support Re Rating

Digital And House-Call Diagnostics Will Transform MENA Healthcare Delivery

Snowflake Analysis

Integrated Diagnostics Holdings plc Key Details

About IDHC

Recent IDHC News & Updates

Less than half of directors are independent

Integrated Diagnostics Holdings plc to Report Q2, 2026 Results on Sep 11, 2026

Hend El Sherbini, the Chief Executive Officer of Integrated Diagnostics Holdings plc and Moamena Abdul Wahab Kamel proposed to acquire 50.38% stake in Integrated Diagnostics Holdings plc (LSE:IDHC) for approximately $150 million.

Recent updates

Integrated Diagnostics Holdings plc Competitors

Advanced Medical Solutions Group

Craneware

NIOX Group

Optima Health